Cabergoline Tablet
Product Images NDC 64380-202

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 64380-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (9319b354 47bb 4057 8832 2c24e920768d 01)

Chemical structure of Cabergoline, illustrating its molecular framework with rings, nitrogen and oxygen atoms, and side chains, corresponding to the active pharmaceutical ingredient Cabergoline.*

FDA Label Image

Label (9319b354 47bb 4057 8832 2c24e920768d 02)

Label for Cabergoline Tablets USP 0.5 mg oral tablets, manufactured by Strides Pharma Inc. The label indicates a package size of 8 tablets and includes dosing and storage instructions. The NDC number 64380-202-01 and distributor information for Strides Pharma Inc., East Brunswick, NJ, are present, along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.